Combination of multiomics approach and BCR-ABL based molecular testing: A better way to monitor treatment regimen and disease progression in Chronic Myeloid Leukemia [HTA-2_0]
Homo sapiens
38 Downloadable Samples
Affymetrix Human Transcriptome Array 2.0 (hta20)
Submitter Supplied Information
Description
We screened TKI-treated-CML-samples in different-phases based on < or >10% copies of BCR-ABL, undetected and control-samples for generating transcriptomics-profile.